PubMed:17255138 / 0-133
Annnotations
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
3881 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | MESH:D052246 |
3882 | 56-62 | ChemicalEntity | denotes | NSAIDs | MESH:D000894 |
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-133 | Sentence | denotes | Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
T2 | 28-38 | GeneOrGeneProduct | denotes | inhibitors |
LitCoin-GeneOrGeneProduct-v2
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
T2 | 28-38 | GeneOrGeneProduct | denotes | inhibitors |
LitCoin-GeneOrGeneProduct-v3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T1 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity |
T2 | 56-62 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T2 | 56-62 | ChemicalEntity | denotes | NSAIDs | ChemicalEntity |
T1 | 22-38 | ChemicalEntity | denotes | COX-2 inhibitors | ChemicalEntity |
T13836 | 22-27 | GeneOrGeneProduct | denotes | COX-2 |